NASDAQ: ABP
Abpro Holdings Inc Stock

$1.04+0.03 (+2.97%)
Updated Feb 14, 2025
ABP Price
$1.04
Fair Value Price
-$0.07
Market Cap
$53.58M
52 Week Low
$0.90
52 Week High
$13.00
P/E
-0.58x
P/B
-0.61x
P/S
345.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$305.00k
Earnings
-$18.43M
Gross Margin
100%
Operating Margin
-6,335.74%
Profit Margin
-6,043.2%
Debt to Equity
-0.17
Operating Cash Flow
-$11M
Beta
0.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ABP Overview

Atlantic Coastal Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or similar business combination with one or more businesses. The company has not disclose its target sector. Atlantic Coastal Acquisition was incorporated in 2021 and is based in New York, NY.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ABP's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -9.02% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
ABP
Ranked
#512 of 561

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important ABP news, forecast changes, insider trades & much more!

ABP News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ABP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABP ($1.04) is overvalued by 1,547.61% relative to our estimate of its Fair Value price of -$0.07 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ABP ($1.04) is not significantly undervalued (1,547.61%) relative to our estimate of its Fair Value price of -$0.07 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ABP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ABP due diligence checks available for Premium users.

Valuation

ABP fair value

Fair Value of ABP stock based on Discounted Cash Flow (DCF)

Price
$1.04
Fair Value
-$0.07
Undervalued by
1,547.61%
ABP ($1.04) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ABP ($1.04) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ABP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ABP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.58x
Industry
-169.22x
Market
37.91x

ABP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.61x
Industry
4.77x

ABP's financial health

Profit margin

Revenue
$183.0k
Net Income
-$2.1M
Profit Margin
-1,143.7%
ABP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ABP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.4M
Liabilities
$15.3M
Debt to equity
-0.17
ABP's short-term liabilities ($15.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ABP's short-term assets ($2.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ABP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ABP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$997.0k
Investing
$0.0
Financing
$936.0k
ABP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ABP vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ABPF$53.58M+2.97%-0.58x-0.61x
AKTX$53.48M-0.64%N/A-7.99x
PRLDD$53.38M+2.11%-0.54x0.34x
ITRMC$53.26M+2.67%-1.22x-13.05x
RPTXD$53.99M+5.83%-0.64x0.31x

Abpro Holdings Stock FAQ

What is Abpro Holdings's quote symbol?

(NASDAQ: ABP) Abpro Holdings trades on the NASDAQ under the ticker symbol ABP. Abpro Holdings stock quotes can also be displayed as NASDAQ: ABP.

If you're new to stock investing, here's how to buy Abpro Holdings stock.

What is the 52 week high and low for Abpro Holdings (NASDAQ: ABP)?

(NASDAQ: ABP) Abpro Holdings's 52-week high was $13.00, and its 52-week low was $0.90. It is currently -92% from its 52-week high and 15.56% from its 52-week low.

How much is Abpro Holdings stock worth today?

(NASDAQ: ABP) Abpro Holdings currently has 51,518,605 outstanding shares. With Abpro Holdings stock trading at $1.04 per share, the total value of Abpro Holdings stock (market capitalization) is $53.58M.

Abpro Holdings stock was originally listed at a price of $10.00 in Jan 14, 2022. If you had invested in Abpro Holdings stock at $10.00, your return over the last 3 years would have been -89.6%, for an annualized return of -52.97% (not including any dividends or dividend reinvestments).

How much is Abpro Holdings's stock price per share?

(NASDAQ: ABP) Abpro Holdings stock price per share is $1.04 today (as of Feb 14, 2025).

What is Abpro Holdings's Market Cap?

(NASDAQ: ABP) Abpro Holdings's market cap is $53.58M, as of Feb 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Abpro Holdings's market cap is calculated by multiplying ABP's current stock price of $1.04 by ABP's total outstanding shares of 51,518,605.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.